Retour
28
Fourchette du Jour
50,70 €
52,95 €
Fourchette 52 Semaines
46,01 €
72,16 €
Volume
1 777 887
Moyenne 50J / 200J
60,87 €
/
57,62 €
Clôture Précédente
52,00 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 111,8 | 0,4 |
| P/B | 4,3 | 2,9 |
| ROE % | 3,7 | 3,9 |
| Net Margin % | 6,0 | 3,8 |
| Rev Growth 5Y % | 7,0 | 10,0 |
| D/E | 0,2 | 0,2 |
Objectif de Cours des Analystes
Hold
69,33 €
+32.2%
Low: 62,00 €
High: 79,00 €
P/E Prévisionnel
26,20
BPA Prévisionnel
1,98 €
Croissance BPA (est.)
+0,0%
CA Est.
1,22B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
3,15 €
3,10 € – 3,21 €
|
1,71B | 1 |
| FY2029 |
3,03 €
2,98 € – 3,08 €
|
1,53B | 1 |
| FY2028 |
2,52 €
2,22 € – 2,76 €
|
1,43B | 3 |
No quarterly estimates available
Dividend History
Yield
0,01%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Revenue grew 6,98% annually over 5 years — modest growth
Earnings declined -56,34% over the past year
ROE of 3,68% is below average
Debt/Equity of 0,23 — conservative balance sheet
Generating 256,55M in free cash flow
P/E of 111,76 — premium valuation
Croissance
Revenue Growth (5Y)
6,98%
Revenue (1Y)5,23%
Earnings (1Y)-56,34%
FCF Growth (3Y)8,95%
Qualité
Return on Equity
3,68%
ROIC3,25%
Net Margin6,02%
Op. Margin8,38%
Sécurité
Debt / Equity
0,23
Current Ratio3,46
Interest Coverage12,02
Valorisation
P/E Ratio
111,76
Forward P/EN/A
P/B Ratio4,27
EV/EBITDA82,98
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5,23% | Revenue Growth (3Y) | 3,58% |
| Earnings Growth (1Y) | -56,34% | Earnings Growth (3Y) | -49,27% |
| Revenue Growth (5Y) | 6,98% | Earnings Growth (5Y) | -14,97% |
| Profitability | |||
| Revenue (TTM) | 1,22B | Net Income (TTM) | 73,40M |
| ROE | 3,68% | ROA | 2,87% |
| Gross Margin | 64,80% | Operating Margin | 8,38% |
| Net Margin | 6,02% | Free Cash Flow (TTM) | 256,55M |
| ROIC | 3,25% | FCF Growth (3Y) | 8,95% |
| Safety | |||
| Debt / Equity | 0,23 | Current Ratio | 3,46 |
| Interest Coverage | 12,02 | ||
| Dividends | |||
| Dividend Yield | 0,01% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 111,76 | Forward P/E | N/A |
| P/B Ratio | 4,27 | P/S Ratio | 6,73 |
| PEG Ratio | -1,97 | Forward PEG | N/A |
| EV/EBITDA | 82,98 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 3,13% | ||
| Market Cap | 8,20B | Enterprise Value | 8,48B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,22B | 1,16B | 1,14B | 1,11B | 931,03M |
| Net Income | 73,40M | 168,11M | 285,26M | 272,05M | 140,41M |
| EPS (Diluted) | 0,46 | 1,05 | 1,76 | 1,66 | 0,87 |
| Gross Profit | 790,27M | 769,73M | 769,82M | 756,50M | 632,85M |
| Operating Income | 102,26M | 206,69M | 298,94M | 296,59M | 237,30M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,56B | 2,70B | 2,64B | 2,29B | 2,26B |
| Total Liabilities | 639,06M | 635,02M | 672,18M | 593,79M | 691,72M |
| Shareholders' Equity | 1,92B | 2,07B | 1,97B | 1,70B | 1,56B |
| Total Debt | 444,06M | 419,54M | 454,97M | 325,97M | 420,55M |
| Cash & Equivalents | 162,19M | 151,79M | 180,57M | 172,57M | 199,09M |
| Current Assets | 608,30M | 617,42M | 621,48M | 605,56M | 510,61M |
| Current Liabilities | 175,85M | 159,38M | 128,51M | 176,02M | 152,28M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#884 of 1052
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026